EveryIntel

Epicypher, Inc.

Publicly observed

Research Triangle Park, United States

Seen in a public record (e.g. a government grant database); not otherwise verified.

Details and provenance

ItemValueSourceStatus
CountryUSNIH RePORTER (opens in a new tab)
28 Sept 2026
Publicly observed
City / localityResearch Triangle ParkNIH RePORTER (opens in a new tab)
28 Sept 2026
Publicly observed
NameEpicypher, Inc.NIH RePORTER (opens in a new tab)
28 Sept 2026
Publicly observed
UEI (U.S. federal entity ID)UWNWSADJYYZ3NIH RePORTER (opens in a new tab)
28 Sept 2026
Publicly observed

Recorded events

  1. Grant1 Sept 2026Publicly observed

    NIH SBIR/STTR award: Genomic profiling of drug-chromatin interactions for accelerated drug development research

    USD 1,062,099.00 · National Center for Advancing Translational Sciences · Source: NIH RePORTER (opens in a new tab)

  2. Grant21 Aug 2026Publicly observed

    NIH SBIR/STTR award: Scalable, single-molecule and single-cell chromatin accessibility profiling in primary immune cells

    USD 999,268.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)

  3. Grant20 Sept 2025Publicly observed

    NIH SBIR/STTR award: Development of novel epigenetic biomarkers and detection reagents for aging

    USD 1,249,682.00 · National Institute on Aging · Source: NIH RePORTER (opens in a new tab)

  4. Grant20 Sept 2025Publicly observed

    NIH SBIR/STTR award: Development of novel epigenetic biomarkers and detection reagents for aging

    USD 1,249,147.00 · National Institute on Aging · Source: NIH RePORTER (opens in a new tab)

  5. Grant1 Sept 2025Publicly observed

    NIH SBIR/STTR award: Asymmetric nucleosome substrates to advance the study of the histone code

    USD 1,264,176.00 · National Institute of General Medical Sciences · Source: NIH RePORTER (opens in a new tab)

  6. Grant1 Sept 2025Publicly observed

    NIH SBIR/STTR award: Asymmetric nucleosome substrates to advance the study of the histone code

    USD 1,264,176.00 · National Institute of General Medical Sciences · Source: NIH RePORTER (opens in a new tab)

  7. Grant25 Sept 2024Publicly observed

    NIH SBIR/STTR award: Versatile platform for genome-wide R-loop mapping for aging and neurodegenerative disease research

    USD 1,274,958.00 · National Institute on Aging · Source: NIH RePORTER (opens in a new tab)

  8. Grant15 Aug 2024Publicly observed

    NIH SBIR/STTR award: Versatile genomics platform for unbiased analysis of chromatin-associated RNAs and nascent transcripts

    USD 1,267,289.00 · National Institute on Aging · Source: NIH RePORTER (opens in a new tab)

  9. Grant1 Mar 2024Publicly observed

    NIH SBIR/STTR award: Biochemical and genomic tools to study histone ADP ribosylation signaling

    USD 1,274,280.00 · National Institute of General Medical Sciences · Source: NIH RePORTER (opens in a new tab)

  10. Grant19 Jul 2023Publicly observed

    NIH SBIR/STTR award: Rapid and robust assay for measurement of in vivo activity of chromatin-interacting proteins

    USD 1,008,869.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)

  11. Grant1 Jul 2023Publicly observed

    NIH SBIR/STTR award: Epigenomic analysis of cell-free nucleosomes for cancer research

    USD 1,047,610.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)

  12. Grant1 Jul 2023Publicly observed

    NIH SBIR/STTR award: Epigenomic analysis of cell-free nucleosomes for cancer research

    USD 1,047,610.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)

  13. Grant1 May 2023Publicly observed

    NIH SBIR/STTR award: Scalable and quantitative chromatin profiling from formalin-fixed paraffin-embedded samples

    USD 1,017,618.00 · National Human Genome Research Institute · Source: NIH RePORTER (opens in a new tab)

  14. Grant10 Mar 2023Publicly observed

    NIH SBIR/STTR award: Development of ultra-efficient antibodies for single cell mapping applications

    USD 1,004,302.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)

Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.